# Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children

> **NCT03943888** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Anesthesia, General
- Neuromuscular Blockade

## Interventions

- **DRUG:** Sugammadex Injection 2mg/kg
- **DRUG:** Sugammadex Injection 4mg/kg
- **DRUG:** Sugammadex Injection 8mg/kg
- **DRUG:** Neuromuscular reversal agent injection

## Key facts

- **NCT ID:** NCT03943888
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-12
- **Primary completion:** 2020-02-20
- **Final completion:** 2020-02-20
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943888, "Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03943888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*